Precision medicine alliance launches

Siemens Healthineers and the University of Missouri System have teamed up to launch a new initiative to transform healthcare delivery with precision medicine with its Alliance for Precision Health. The alliance will focus on cancer, Alzheimer’s disease, cardiovascular disease and more, according to a press release.

The initiative is a 10-year agreement with four main pillars:

  • Healthcare delivery
  • Education and workforce development
  • Healthcare innovation
  • Research and collaboration

Germany-based Siemens Healthineers is the parent company of several medical technology companies, and the alliance will be anchored by the University of Missouri’s NextGen Precision Health Institute. The institute is a $220.8 million project by the University of Missouri that broke ground June 21. It is expected to be completed October 2021. The space will include laboratories and classrooms for faculty, researchers and industry partners to “focus on precision medicine and digital health,” according to a press release.

Under the education and workforce development pillar, the two organizations will develop a curricula that focuses on AI in healthcare, cybersecurity, data science and machine learning in the field.

The alliance ensures that UM System’s universities and University of Missouri Health Care can use the latest diagnostic and therapeutic equipment and digital health solutions. Siemens Healthineers can gain insights from real-world adoption of these tools in the UM System.

“Our vision for the entire UM System is to advance the opportunities for success and well-being in Missouri, the nation and the world through transformative teaching, research, innovation, engagement and inclusion,” UM System President Mun Y. Choi said in a statement. “Forming an alliance with Siemens Healthineers enables us to work toward this mission by providing our University and health system with leading-edge technology and resources, unique research and collaboration opportunities, training for the next generation of the healthcare workforce and expansion of our contributions to medicine and healthcare to rural Missouri and beyond.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.